|
|
||||||||
J Thorac Cardiovasc Surg 2009;138:880-885
© 2009 The American Association for Thoracic Surgery
Acquired Cardiovascular Disease |
a Department of Surgical Sciences, Vascular Surgery Unit, Varese University Hospital, Varese, Italy
b Department of Surgical Sciences, Cardiac Surgery Unit, Varese University Hospital, Varese, Italy
c Department of Radiology, Varese University Hospital, Varese, Italy
d Anaesthesia and Palliative Care, Varese University Hospital, Varese, Italy
e Department of Cardiac Surgery, 1st Chair of Cardiology and Cardiac Surgery, Medical University of Lodz, Lodz, Poland
Received for publication July 10, 2008; revisions received December 5, 2008; accepted for publication February 3, 2009. * Address for reprints: Giovanni Mariscalco, MD, PhD, Department of Surgical Sciences, Cardiac Surgery Unit, Varese University Hospital, University of Insubria, Viale Guicciardini 9, 21100 Varese, Italy. (Email: giovannimariscalco{at}yahoo.it).
Background: Our prospective investigation aimed to determine and analyze the incidence and the determinants of endoleaks after thoracic stent graft.
Methods: Sixty-one patients affected by thoracic aortic aneurysms were treated between January 2000 and March 2008. The study cohort contained 54 men, with a mean age of 63.6 ± 17.9 years. The follow-up imaging protocol included chest radiographs and triple-phase computed tomographic angiography performed at 1, 4, and 12 postoperative months and annually thereafter.
Results: Median follow-up was 32.4 months (range: 1–96 months). Endoleaks were detected in 9 (14.7%) patients, of which 7 were type 1. Five endoleaks were detected at 30 postoperative days, and the other 4 developed with a mean delay of 12 months. Endovascular or hybrid interventions were used to treat the endoleaks. Secondary technical success rate was 100%. Multivariate analysis demonstrated that the diameter of the aneurysmal aorta (odds ratio 1.75, 95% confidence interval 1.07–2.86) and the coverage of the left subclavian artery (odds ratio 12.05, 95% confidence interval 1.28–113.30) were independently associated with endoleak development. The percentages of patients in whom reinterventions were unnecessary were 94.6% ± 3.0%, 88.3% ± 4.5%, and 85.4% ± 5.2%, at 1, 2, and 5 years, respectively. The actuarial survival estimates at 1, 2, and 5 years were 85.2% ± 4.6%, 78.1% ± 5.4%, and 70.6% ± 6.4%, respectively.
Conclusions: The diameter of the aneurysmal aorta and the position of the landing zone are independent predictors of endoleak occurrence after thoracic stent-graft procedures. A careful follow-up program should be considered in patients in whom these indices are unfavorable, because most of the endoleaks may be successfully and promptly treated by additional endovascular procedures.
This article has been cited by other articles:
![]() |
G. J. Wang, B. M. Jackson, E. Y. Woo, J. E. Bavaria, N. D. Desai, A. Pochettino, and R. M. Fairman ''Relining'' of Thoracic Aortic Stent Grafts for Patients Presenting With Rupture/Impending Rupture Vascular and Endovascular Surgery, July 1, 2011; 45(5): 438 - 441. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |